OXYNORM

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Spain, Finland, France, Hong Kong, Ireland, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug OXYNORM contains one active pharmaceutical ingredient (API):

1 Oxycodone
UNII C1ENJ2TE6C - OXYCODONE HYDROCHLORIDE

Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative.

Read about Oxycodone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
OXYNORM Concentrate oral solution Υπουργείο Υγείας (CY) MPI, EU: SmPC
OXYNORM 10 mg/ml Solution for injection or infusion Υπουργείο Υγείας (CY) MPI, EU: SmPC
OXYNORM Capsule, hard Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02AA05 Oxycodone N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 12031F, 12074L, 12311Y, 12314D, 5190E, 5191F, 5197M, 8464L, 8501K, 8502L, 8644Y
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 556721030004905, 556721030005005
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 66574, 66575, 66576, 66614, 71243
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 003449, 003485, 004795, 005068, 005088, 006244, 006255, 006263, 022119
Country: FR Base de données publique des médicaments Identifier(s): 60209645, 60629186, 61007415, 61115864, 61613434, 65821685, 66268312, 67565715, 68127381
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 155455, 162207, 162209, 162211, 186052, 186054, 28958, 28961, 28964, 28976, 28984, 376967, 376969, 376971, 381590, 46355, 46361
Country: HK Department of Health Drug Office Identifier(s): 59575, 59576, 59577, 61835, 66357, 66358
Country: IE Health Products Regulatory Authority Identifier(s): 38149, 38162, 38174, 38196, 38239, 38546, 38710, 59007, 59017, 59024, 59073
Country: NL Z-Index G-Standaard Identifier(s): 14903547, 14930978
Country: NL Z-Index G-Standaard, PRK Identifier(s): 68209, 68217, 68225, 70726, 72761, 94374, 94390, 94412
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11876, 12258, 13456, 9550, 9551, 9552
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100206840
Country: SG Health Sciences Authority Identifier(s): 13079P, 13081P, 13083P, 13733P, 14125P, 14126P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 16263021, 16263022, 16263023
Country: ZA Health Products Regulatory Authority Identifier(s): 41/2.9/1103, 41/2.9/1104, 41/2.9/1105, 46/2.9/0718, 46/2.9/0719

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.